Publications by authors named "Kyunglan Moon"
Background: This study is designed to evaluate the main hypothesis that nafamostat mesilate with standard therapy improves the severity and mortality rate in patients with COVID-19 pneumonia.
Methods: We conduct a randomized, open type, multi-institute/center, 2-group clinical trial with COVID-19 pneumonia patients in Korea. Eighty four patients with COVID-19 pneumonia are randomly assigned to intervention group or control group.
Background: The South Korean government has been combating the coronavirus disease 2019 (COVID-19) outbreak using public information and extensive viral screening. We describe the application of the Korean response system in Gyeongsangnam-do province and outline the epidemiological features of COVID-19 in the cohort.
Methods: A Rapid Response Team tracked the patients' activities and identified close contacts.
Article Synopsis
- The study aimed to compare the clinical characteristics and outcomes of patients with two types of bloodstream infections (BSIs) over a 9-year period at a tertiary hospital.
- A total of 37 cases of one type of BSI were matched with 160 cases of another type, revealing that those with the first BSI were more likely to have biliary tract diseases and community-acquired infections.
- The main focus of infection was intra-abdominal, with a higher prevalence of biliary tract infections and pancreatitis in the first BSI group, though mortality rates after 14 and 30 days were lower but not significantly different between the two groups.
Background: The neutrophil-to-lymphocyte ratio (NLR) has been known to predict the prognosis in diffuse large B-cell lymphoma (DLBCL). We planned to design a new prognostic model in DLBCL using well-known prognostic index and NLR.
Methods: The data of 232 DLBCL patients treated with first-line R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) from 2004 to 2017 were retrospectively reviewed.